| Literature DB >> 27108687 |
Renaud Greget1, Selma Dadak2, Laure Barbier3, Fabien Lauga3, Sandra Linossier-Pierre3, Fabien Pernot1, Arnaud Legendre1, Nicolas Ambert1, Jean-Marie Bouteiller1, Frédéric Dorandeu4, Serge Bischoff1, Michel Baudry1, Laurent Fagni2, Saliha Moussaoui5.
Abstract
Exposure to organophosphorus (OP) compounds, either pesticides or chemical warfare agents, represents a major health problem. As potent irreversible inhibitors of cholinesterase, OP may induce seizures, as in status epilepticus, and occasionally brain lesions. Although these compounds are extremely toxic agents, the search for novel antidotes remains extremely limited. In silico modeling constitutes a useful tool to identify pharmacological targets and to develop efficient therapeutic strategies. In the present work, we developed a new in silico simulator in order to predict the neurotoxicity of irreversible inhibitors of acetyl- and/or butyrylcholinesterase (ChE) as well as the potential neuroprotection provided by antagonists of cholinergic muscarinic and glutamate N-methyl-d-aspartate (NMDA) receptors. The simulator reproduced firing of CA1 hippocampal neurons triggered by exposure to paraoxon (POX), as found in patch-clamp recordings in in vitro mouse hippocampal slices. In the case of POX intoxication, it predicted a preventing action of the muscarinic receptor antagonist atropine sulfate, as well as a synergistic action with the non-competitive NMDA receptor antagonist memantine. These in silico predictions relative to beneficial effects of atropine sulfate combined with memantine were recapitulated experimentally in an in vivo model of POX in adult male Swiss mice using electroencephalic (EEG) recordings. Thus, our simulator is a new powerful tool to identify protective therapeutic strategies against OP central effects, by screening various combinations of muscarinic and NMDA receptor antagonists.Entities:
Keywords: Acetyl- and/or butyryl-cholinesterase; Acetylcholine; N-Methyl-d-aspartate; Organophosphorus; Paraoxon; γ-Aminobutyric acid
Mesh:
Substances:
Year: 2016 PMID: 27108687 DOI: 10.1016/j.neuro.2016.04.013
Source DB: PubMed Journal: Neurotoxicology ISSN: 0161-813X Impact factor: 4.294